Ritter Pharmaceuticals

(RTTR) Trade

Symbol has changed to a new ticker symbol

(QLGN)

By |

Profile

Ritter Pharmaceuticals Inc develops novel therapeutic products that modulate the gut microbiome to treat gastrointestinal diseases. Its lead product, RP-G28 is designed to stimulate the growth of lactose-metabolizing bacteria in the colon thereby effectively adapting the gut microbiome to assist in digesting lactose that reaches the large intestine.

Contact Information

Website: www.ritterpharmaceuticals.com
Main Phone: +1 310 203-1000
Address: 1880 Century Park East
Address 2: Suite 1000
State: CA
City / Town: Los Angeles
Country: US
Postal Code: 90067

Issuer Information

Exchange: NSC
CEO: Andrew J. Ritter
Employees: 5
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

Profile

Ritter Pharmaceuticals Inc develops novel therapeutic products that modulate the gut microbiome to treat gastrointestinal diseases. Its lead product, RP-G28 is designed to stimulate the growth of lactose-metabolizing bacteria in the colon thereby effectively adapting the gut microbiome to assist in digesting lactose that reaches the large intestine.

Contact Information

Website: www.ritterpharmaceuticals.com
Main Phone: +1 310 203-1000
Address: 1880 Century Park East
Address 2: Suite 1000
State: CA
City / Town: Los Angeles
Country: US
Postal Code: 90067

Issuer Information

Exchange: NSC
CEO: Andrew J. Ritter
Employees: 5
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size 0.00 Ask N/A Ask Size 0.00
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume 0 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 1,846,118.00 EPS (TTM) -14.00 PE Ratio N/A Exchange NCM
  Last 3 Mo Last 12 Mo
Number of Insider Trades 0 3
Number of Buys 0 3
Number of Sells 0 0
Net Activity 0 5375000
Last 10 Buys Shares
Andrew J. Ritter 1,000
Ira E. Ritter 1,000
Noah J. Doyle 1,000
Matthew W. Foehr 1,000
Michael D. Step 1,000
Michael D. Step 1,000
Michael D. Step 1,000
Ira E. Ritter 1,000
Andrew J. Ritter 1,000
Matthew W. Foehr 1,000
Last 10 Sell Shares
N/A 0
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 15 15 15 15
Low Target Price Estimate 12 12 12 12
Mean Target Price Estimate 13.5 13.5 13.5 13.5
Standard Deviation 2.12 2.12 2.12 2.12
Date of Most Recent Estimate 05/29/18 05/29/18 05/16/18 05/29/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 2 2 2 2
Moderate Buy 0 0 0 0
Hold 0 0 0 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1.67